COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients (NKCell)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00846157
Recruitment Status : Unknown
Verified February 2009 by NKBio Co.Ltd..
Recruitment status was:  Enrolling by invitation
First Posted : February 18, 2009
Last Update Posted : June 28, 2011
Information provided by:
NKBio Co.Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2011
Estimated Study Completion Date : September 2014